These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9310575)

  • 1. Impact of postmenopausal hormone therapy on cardiovascular events and cancer. More women are excluded from treatment arm of such trials because of cardiovascular events.
    Singleton S; Bailey K
    BMJ; 1997 Sep; 315(7109):676. PubMed ID: 9310575
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from 2 large clinical trials.
    Lobo RA
    Arch Intern Med; 2004 Mar; 164(5):482-4. PubMed ID: 15006823
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M
    Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T; Mannella P; Genazzani AR
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Paper's main conclusion is no longer justified when data from all trials are considered.
    Seagroatt V
    BMJ; 1997 Sep; 315(7109):677; author reply 678-9. PubMed ID: 9310577
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Study's conclusions were incorrect.
    Col NF; Wong JB; Pauker SG; Karas R
    BMJ; 1997 Sep; 315(7109):678; author reply 678-9. PubMed ID: 9310580
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement therapy (ERT) and hormone replacement therapy (HRT) in the prevention of cardiovascular diseases.
    Nikolov R; Golbs S; Schneider HP
    Zentralbl Gynakol; 1999; 121(2):101-4. PubMed ID: 10096179
    [No Abstract]   [Full Text] [Related]  

  • 12. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T; Jaillon P
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 15. Menopause and the epidemiology of cardiovascular disease in women.
    Perlman J; Wolf P; Finucane F; Madans J
    Prog Clin Biol Res; 1989; 320():283-312. PubMed ID: 2602441
    [No Abstract]   [Full Text] [Related]  

  • 16. [Does postmenopausal hormone replacement therapy have a place in treatment of hyperlipidemia?].
    Tonstad S; Os I
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):923-6. PubMed ID: 10795496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy and cardiovascular disease--still much to be learnt.
    Mikkola TS; Ylikorkala O
    Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risks and benefits of postmenopausal hormone replacement therapy].
    Szántó F
    Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
    Modena MG; Rossi R; Muia N; Origliani G; Rombolà O; Molinari R
    G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.